Has John Daly, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,155 in general payments to John Daly, MD across 19 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Daly, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Daly, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Daly, MD

Internal Medicine · West Deptford, NJNPI 1801835905

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Novo Nordisk at 37.9% of the total. Reporting peaked in 2019 at $338 and has fallen 72.4% since, to $93 in 2025.

$1,155in general payments, 2019–2025

Across 19 payments — averaging $60.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$438
Abbott$263
Teva Pharmaceuticals USA, Inc.$133
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$125
Intra-sana Laboratories$114
Otsuka America Pharmaceutical, Inc.$39
plus $42 from 2 others

What the payments were for

Food & beverage$1,155100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	7	$438
Abbott	2	$263
Teva Pharmaceuticals USA, Inc.	3	$133
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$125
Intra-sana Laboratories	1	$114
Otsuka America Pharmaceutical, Inc.	2	$39
Astellas Pharma US Inc	2	$27
Exact Sciences	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,155 in reported general payments places this provider in the 70th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey →

Medicare billing

Part B allowed, 2024

$198,975

Medicare patients

139

Services billed

1,099

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	70	$49,012
XareltoRivaroxaban	32	$20,757
NamzaricMemantine Hcl/Donepezil Hcl	13	$7,171
Breo ElliptaFluticasone/Vilanterol	18	$5,096
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate	12	$2,720
Memantine Hcl	50	$2,334
Arnuity ElliptaFluticasone Furoate	11	$2,313
Atorvastatin Calcium	209	$2,071
Levothyroxine Sodium	127	$1,434
Mirtazapine	48	$1,336
Methenamine Hippurate	12	$1,155
Escitalopram Oxalate	103	$1,151
Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc	11	$1,147
Gabapentin	68	$1,140
Metoprolol Succinate	108	$1,132

Paid to pharmacies, not to this prescriber.

Other internal medicine in West Deptford

David ShulkinMorristown$1.7M
Howard UdermanLakewood$955K
Darshi SunderamEast Orange$530K
Annika DrongeEmerson$401K
Stephen MarcellaNew Brunswick$331K
Viju VijaysadanKinnelon$325K
Mark MonaneWoodcliff Lake$268K
Martin BedigianLivingston$240K
Rameck HuntPlainsboro$217K
Angel LazoSecaucus$195K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →